There was an observed trend towards K trans recovery by 24-weeks, which preceded the median progression free survival by 8-weeks and therefore potentially an earlier marker of disease progression [ 25 ].
← all excerpts
Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer.
1
—
—